Across multiple xenograft models, including pancreatic ductal adenocarcinoma, neuroblastoma, glioma, and rhabdomyosarcoma, all three fully human B7-H3 CAR T cells mediated substantial anti-tumor activity. This evidence concerns the gene CD276 and glioma.